| OCR Text |
Show 3.6. Eticlopride pretreatment attenuates METH-induced OAT complex formation and loss of OAT monomer immunoreactivity, as assessed 7 dafter METH- 54 treatment 3.7. Eticlopride pretreatment attenuates METH-induced loss of VMAT2 and increase in GFAP immunoreactivity, as assessed 7 dafter METH56 treatment 4.1. Immunoprecipitation of OAT and OAT-interacting proteins from rat striatal 69 synaptosomes 4.2. Co-immunoprecipitation of known OAT-interacting proteins 73 4.3. Confirmation of OAT-NSF interaction by immunoprecipitation and reciprocal 75 immunoprecipitation viii |
